Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
